Literature DB >> 9083026

Metal-catalyzed oxidation of histidine in human growth hormone. Mechanism, isotope effects, and inhibition by a mild denaturing alcohol.

F Zhao1, E Ghezzo-Schöneich, G I Aced, J Hong, T Milby, C Schöneich.   

Abstract

Metal-catalyzed oxidation of proteins represents an important pathway of post-translational modification. We utilized human growth hormone (hGH), a protein with a well defined metal-binding site, to study the detailed mechanism of metal-catalyzed oxidation by ascorbate/Cu(II)/O2. Particularly His18 and His21 within the metal-binding site were oxidized, predominantly to 2-oxo-His with the incorporated oxygen originating from molecular oxygen, based on amino acid analysis, tryptic mapping, mass spectrometry, isotopic labeling, and 1H NMR. The anaerobic reduction of a hGH/Cu(II) mixture by ascorbate generated a hGH-Cu(I) complex with NMR spectral features different from those of native hGH and hGH/Cu(II). The anaerobic reaction of this hGH-Cu(I) complex with hydrogen peroxide resulted in the oxidation of His18 and His21, suggesting that a fraction of Cu(I) was bound at the metal-binding site of hGH. Site-specific oxidation of hGH required an intact metal-binding site and could largely (about 80%) be inhibited by the presence of >/=28% (v/v) 1-propanol which appears (i) to perturb the metal-binding site and (ii) to interact with a reactive oxygen species formed at the perturbed metal-binding site. The inhibition by 1-propanol-d7 (CD3CD2CD2OH) was significantly lower than that by 1-propanol-h7 with [residual hGH]1-propanol-h7/[residual hGH]1-propanol-d7 = 1.95 at 30% (v/v) 1-propanol, reflecting a kinetic isotope effect close to that for the reaction of a hydroxyl radical with Calpha-H/D bonds of methanol, suggesting the involvement of a hydroxyl radical-like species in the oxidation of His.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083026     DOI: 10.1074/jbc.272.14.9019

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  2-Oxo-histidine-containing dipeptides are functional oxidation products.

Authors:  Hideshi Ihara; Yuki Kakihana; Akane Yamakage; Kenji Kai; Takahiro Shibata; Motohiro Nishida; Ken-Ichi Yamada; Koji Uchida
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

2.  The effect of histidine oxidation on the dissociation patterns of peptide ions.

Authors:  Juma D Bridgewater; R Srikanth; Jihyeon Lim; Richard W Vachet
Journal:  J Am Soc Mass Spectrom       Date:  2006-12-08       Impact factor: 3.109

Review 3.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

4.  Complex Nature of Protein Carbonylation Specificity After Metal-Catalyzed Oxidation.

Authors:  Dmitry Kryndushkin; Wells W Wu; Ramesh Venna; Michael A Norcross; Rong-Fong Shen; V Ashutosh Rao
Journal:  Pharm Res       Date:  2017-02-01       Impact factor: 4.200

5.  Using metal-catalyzed oxidation reactions and mass spectrometry to identify amino acid residues within 10 A of the metal in Cu-binding proteins.

Authors:  Juma D Bridgewater; Jihyeon Lim; Richard W Vachet
Journal:  J Am Soc Mass Spectrom       Date:  2006-07-26       Impact factor: 3.109

6.  Chemical modifications in therapeutic protein aggregates generated under different stress conditions.

Authors:  Quanzhou Luo; Marisa K Joubert; Riki Stevenson; Randal R Ketchem; Linda O Narhi; Jette Wypych
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 7.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

8.  An Efficient and Rapid Method to Monitor the Oxidative Degradation of Protein Pharmaceuticals: Probing Tyrosine Oxidation with Fluorogenic Derivatization.

Authors:  Rupesh Bommana; Olivier Mozziconacci; Y John Wang; Christian Schöneich
Journal:  Pharm Res       Date:  2017-04-18       Impact factor: 4.200

Review 9.  Photo-Degradation of Therapeutic Proteins: Mechanistic Aspects.

Authors:  Christian Schöneich
Journal:  Pharm Res       Date:  2020-02-03       Impact factor: 4.200

10.  Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan.

Authors:  Fei Gao; Jeffrey R Koenitzer; Jacob M Tobolewski; Dianhua Jiang; Jiurong Liang; Paul W Noble; Tim D Oury
Journal:  J Biol Chem       Date:  2007-12-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.